Amgen's stock soars
12:04 PM Thu, Apr 10, 2008 | Permalink
Email this author | Email this entry |
 |
Projo Biz Blog |
|
« Mayor to sign bill to help artists and small businesses |
Main
| $5 million granted for house acquisitions near T.F. Green »
Stock in Amgen (AMGN:NASDAQ) gained the most in the Standard & Poor's 500 Index this morning, rising 6 percent to $44.15 a share, up $2.56. U.S. District Judge William Young ruled Roche Holding AG's anemia medicine Mircera violates patents owned by Amgen. Roche was banned from selling the drug for now. Young is considering Amgen's request that the ban continue until its patents expire. Amgen, based in California, manufactures Enrel, a rheumatoid arthritis drug, at a plant in West greenwich. 
|
New comments
New photos
Authors
New posts
Projo blogs
Archives
Leave a comment